‌

US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Patent 7449458 was granted and assigned to Rigel Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

Rigel Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Somasekhar Bhamidipati0

Rajinder Singh0

Thomas Sun0

Valentino J. Stella0

Date of Patent

November 11, 2008

0

Patent Application Number

113370490

Date Filed

January 19, 2006

0

Patent Citations Received

US Patent 12091411 IRAK degraders and uses thereof

0

US Patent 11707457 IRAK degraders and uses thereof

0

US Patent 11746120 Stat degraders and uses thereof

US Patent 11779578 IRAK degraders and uses thereof

US Patent 11932635 CRBN ligands and uses thereof

0

US Patent 11932624 MDM2 degraders and uses thereof

0

US Patent 12006329 Protein degraders and uses thereof

0

US Patent 12077555 STAT degraders and uses thereof

0

...

Patent Primary Examiner

Kahsay T. Habte

0

Patent abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds of structural formula shown below, compositions comprising these compounds, intermediates and methods for synthesizing these compounds, and methods for using these compounds in a variety of applications including treatment of autoimmune diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.